γ-Hydroxybutyrate intoxication and overdose [2] (multiple letters)

Annals of Emergency Medicine

Volumn 33, Issue 4, 1999, Pages 475-476

  Kohrs, F P ^a   Porter, W H ^a   Li, J ^a   Chin, R L ^a   Dyer, J E ^a   Sporer, K A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; GAMMA BUTYROLACTONE;

DRUG ABSORPTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INTOXICATION; DRUG METABOLISM; DRUG OVERDOSE; DRUG SCREENING; DRUG SOLUBILITY; DRUG USE; HUMAN; LETTER; MASS SPECTROMETRY; PRIORITY JOURNAL;

EID: 0032895939     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0196-0644(99)70320-3     Document Type: Letter

References (7)

1. RL Chin KA Sporer B Cullison Clinical course of gamma-hydroxybutyrate overdose Ann Emerg Med 31 1998 716 722
2. J Li SA Stokes A Woeckener A tale of novel intoxication: Seven cases of gamma-hydroxybutyric acid overdose Ann Emerg Med 31 1998 723 728
3. J Li SA Stokes A Woeckener A tale of novel intoxication: A review of the effects of gamma-hydroxybutyric acid with recommendations for management Ann Emerg Med 31 1998 729 736
4. J Lettieri H Fung Improved pharmacological activity via pro-drug modification: Comparative pharmacokinetics of sodium gamma-hydroxybuturate and gamma-butyrolactone Res Commun Chem Pathol Pharmacol 22 1978 107 118
5. SD Ferrara L Tedeschi G Frison Therapeutic gamma-hydroxybutyric acid monitoring in plasma and urine by gas chromatography-mass spectrometry J Pharm Biomed Anal 11 1993 483 487
6. RH Roth JMR Delgado NJ Giarman Gamma-butyrolactone and gamma-hydroxybutyric acid—II. The pharmacologically active form Int J Neuropharmacol 5 1966 421 428
7. F LoVecchio SC Curry T Bagnasco Butyrolactone-induced central nervous system depression after ingestion of RenewTrient, a “dietary supplement” N Engl J Med 339 1998 847 848